Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PetMed ExpressPETS +0.76%56 12-1 Month Momentum % is -38.26% as of Aug. 09, 2026. GuruFocus rates PETS with a GF Score™ of 56/100 and a GF Value™ of $2.76 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 656 Healthcare Providers & Services companies, PetMed Express ranks worse than 80.49% on this metric.
12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2026-08-09), PetMed Express's 12-1 Month Momentum % is -38.26%.
The industry rank for PetMed Express's 12-1 Month Momentum % or its related term are showing as below:
PETS's 12-1 Month Momentum % is ranked worse than 80.49% of 656
companies
in the Healthcare Providers & Services industry
Industry Median: -12.555
vs PETS: -38.26
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
PetMed Express 12-1 Month Momentum % Related Terms
PETS vs BHIC, SCNX, HEWA: 12-1 Month Momentum % Comparison
For the Pharmaceutical Retailers subindustry, PetMed Express's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PetMed Express 12-1 Month Momentum % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PetMed Express's 12-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where PetMed Express's 12-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a 12-1 Month Momentum % of -38.26% mean?
PetMed Express (PETS) has a 12-1 Month Momentum % of -38.26% as of Aug. 09, 2026. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on PetMed Express and its competitors. According to the industry distribution chart, PetMed Express ranks #528 out of 656 companies in the Healthcare Providers & Services industry, placing it in the top 80.5%.
Is PetMed Express' 12-1 Month Momentum % too high?
PetMed Express' current 12-1 Month Momentum % is -38.26%. Based on the distribution chart, PetMed Express ranks #528 out of 656 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, PetMed Express has a GF Score™ of 56/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PetMed Express' 12-1 Month Momentum % compare to BHIC and SCNX?
According to the Healthcare Providers & Services industry distribution chart, PetMed Express ranks #528 out of 656 companies for 12-1 Month Momentum %. This places PetMed Express in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 12-1 Month Momentum % for a Healthcare Providers & Services company?
A good 12-1 Month Momentum % depends on the Healthcare Providers & Services industry context. However, 12-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 12-1 Month Momentum % mean?
A high 12-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on PetMed Express and its competitors. PetMed Express's current 12-1 Month Momentum % is -38.26%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PetMed Express stock overvalued right now?
Based on GuruFocus' analysis, PetMed Express (PETS) is currently considered Modestly Undervalued. The stock's GF Value™ is $2.76, compared to a current price of $1.98 — trading 28.3% below its estimated fair value. The current 12-1 Month Momentum % is -38.26%. PetMed Express' overall GF Score™ is 56/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 12-1 Month Momentum % calculated?
12-1 Month Momentum % is calculated from a company's financial statements. For PetMed Express (PETS), the current 12-1 Month Momentum % is -38.26% as of Aug. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PetMed Express (PETS) Overvalued in 2026?
Based on GuruFocus' analysis, PetMed Express stock appears to be undervalued.
The current stock price of $1.98 is trading 28.3% below its estimated GF Value™ of $2.76.
GuruFocus considers PetMed Express to be Modestly Undervalued.
Key valuation signals for PETS:
12-1 Month Momentum %: -38.26%
GF Value™: $2.76 vs. price of $1.98 (28.3% below fair value)
No single metric tells the full story. See the PETS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PetMed Express Inc is a nationwide direct-to-consumer pet pharmacy and online provider of prescription and non-prescription medications, foods, supplements, supplies, and vet services for dogs, cats, and horses. It markets and sells directly to consumers through its websites, toll-free numbers, and mobile application, offering convenience, price, speed of delivery, and customer service. It provides access to branded pharmaceuticals, generic medications, compounded prescription medications, over-the-counter health and wellness products, prescription and non-prescription food, pharmacy fulfillment, and AutoShip capabilities. Its digital platform offers pet healthcare solutions for chronic conditions, including allergies, arthritis, anxiety, kidney-related conditions, and hyperthyroidism.
56GF Score
Get the complete analysis for PETS
12-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PETS has been successfully added to your 
